• Alan F. Casy
  • Robert T. Parfitt


This book deals with substances commonly described as analgesics or analgetics that alleviate or abolish pain without at the same time inducing loss of consciousness. Their site of action is essentially within the central nervous system whereby they are distinguished from pain-relieving drugs such as aspirin and other anti-inflammatory agents that act at peripheral locations. Their central actions are depressant but they may be differentiated from general agents of this description such as barbiturates and anesthetics in that they influence specific sites, those concerned with the appreciation of pain and the control of respiration being the most notably affected. Nowadays a distinction is made between the terms opiate and opioid as applied to central analgesics. The former term refers to agents derived from opium or one of its constituents, while the latter is the more general term for agents with morphinelike properties; hence, the title of this book, Opioid Analgesics.


Opioid Receptor Biochemical Pharmacology Abstinence Syndrome Tooth Pulp Narcotic Antagonist 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    L. E. Robson, S. J. Paterson, and H. W. Kosterlitz, in: Handbook of Psychopharmacology (L. Iverson, S. D. Iverson, and S. H. Snyder, eds.), Vol. 17, p. 13, Plenum Press, New York (1983).Google Scholar
  2. 2.
    H. O. J. Collier, in: Evaluation of Drug Activities and Pharmacometrics (D. R. Laurence and A. L. Bacharach, eds.), p. 183, Academic Press, London (1964).Google Scholar
  3. 3.
    A. H. Beckett and A. F. Casy, Prog. Med. Chem. 2, 43 (1962).CrossRefGoogle Scholar
  4. 4.
    R. D. E. Sewell and P. S. J. Spencer, Prog. Med. Chem. 14, 249 (1977).PubMedCrossRefGoogle Scholar
  5. 5.
    J. Jacob, in: Methods in Drug Evaluation (P. Mantegazza and F. Piccinini, eds.), p. 278, North-Holland, Amsterdam (1966).Google Scholar
  6. 6.
    T. J. Haley and W. G. McCormick, Br. J. Pharmacol. 12, 12 (1957).Google Scholar
  7. E. Kutter, A. Herz, H.-J. Teschemacher, and R. Hess, J. Med. Chem. 13, 801 (1970).PubMedCrossRefGoogle Scholar
  8. 7.
    L. B. Mellet and L. A. Woods, Prog. Drugs. Res. 5, 155 (1963).Google Scholar
  9. L. Atwell and A. E. Jabcobson, Lab. Anim. 7, 42 (1978).Google Scholar
  10. 8.
    A. F. Casy, Prog. Med. Chem. 7, (part 2), 229 (1970).CrossRefGoogle Scholar
  11. 9.
    S. G. Dennis, R. Melzack, S. Gutman and F. Boucher, Life Sci. 26, 1247 (1980).PubMedCrossRefGoogle Scholar
  12. 10.
    H. W. Kosterlitz and A. A. Waterfield, Ann. Rev. Pharmacol. 15, 29 (1975).PubMedCrossRefGoogle Scholar
  13. 11.
    A. Goldstein, Proc. Natl. Acad. Sci. USA 68, 1742 (1971).PubMedCrossRefGoogle Scholar
  14. 12.
    D. W. Littlejohns and D. W. Vere, in: Methods in Clinical Pharmacology (M. H. Lader and A. Richens, eds.), p. 125, Macmillan, London (1981).Google Scholar
  15. 13.
    J. Parkhouse, B. J. Pleuvry, and J. M. H. Rees, Analgesic Drugs, Blackwells, Oxford, 1979.Google Scholar
  16. 14.
    J. H. Jaffe and W. R. Martin, in: The Pharmacological Basis of Therapeutics (L. S. Goodman and A. Gilman, eds.), 6th ed., p. 494, Macmillan, New York (1980).Google Scholar
  17. 15.
    A. Wikler, Opioid Dependence, Plenum Press, New York (1980).CrossRefGoogle Scholar
  18. W. R. Martin (ed.), Drug Addiction, Handbook of Experimental Pharmacology, Vol. 45, Part 1, Springer-Verlag, Berlin (1977).Google Scholar
  19. 16.
    R. Melzack and P. Wall, The Challenge of Pain, Penguin, Harmondsworth (1982).Google Scholar
  20. 17.
    H. F. Fraser, in: Methods in Drug Evaluation (P. Mantegazza and F. Piccinini, eds.), p. 297, North-Holland, Amsterdam (1966).Google Scholar
  21. 18.
    J. K. Saelens, F. R. Granat, and W. K. Sawyer, Arch. Int. Pharmacodyn. 190, 213 (1971).PubMedGoogle Scholar
  22. 19.
    P. F. Von Voigtlander, in: Central Analgetics (D. Lednicer, ed.), p. 62, Wiley, New York (1982).Google Scholar
  23. 20.
    G. K. W. Lim, H. H. Keasling, E. G. Gross, and C. W. Mitchell, J. Pharmacol. Exp. Ther. 115, 96 (1955).Google Scholar
  24. G. Kaczmarczyk and H. W. Reinhardt, Lab. Anim. Sci. 25, 184 (1975).PubMedGoogle Scholar
  25. 21.
    T. F. Burks and J. P. Long, Proc. Soc. Exp. Biol Med. 125, 227 (1967).PubMedCrossRefGoogle Scholar
  26. 22.
    T. J. Cicero, C. E. Wilcox, R. D. Bell, and E. R. Meyer, J. Pharmacol. Exp. Ther. 212, 573 (1980).PubMedGoogle Scholar
  27. E. L. Lien, A. Morrison, and W. Dvonch, Life Sci. 25, 1707 (1979).CrossRefGoogle Scholar
  28. K. M. Foley, I. A. Kourides, C. E. Inturrisi, R. F. Kaiko, C. G. Zaroulis, J. B. Posner, R. W. Houde, and C. H. Li, Proc. Natl. Acad. Sci. USA 76, 5377 (1979).PubMedCrossRefGoogle Scholar
  29. 23.
    S. G. Holtzman, J. Pharmacol. Exp. Ther. 214, 614 (1980).PubMedGoogle Scholar
  30. A. H. Tang and S. R. Franklin, Fed. Proc. 40, 288 (1981).Google Scholar
  31. 24.
    E. L. Way and T. K. Adler, Pharmacol. Rev. 12, 383 (1960).PubMedGoogle Scholar
  32. E. L. Way and T. K. Adler, Bull. World Hlth. Org. 25, 227 (1961); 26, 51, 261, 359 (1962).Google Scholar
  33. 25.
    L. Decsi, Prog. Med. Chem. 8, 131 (1965).CrossRefGoogle Scholar
  34. 26.
    D. H. Clouet (ed.), Narcotic Drugs: Biochemical Pharmacology, Plenum Press, New York (1971).Google Scholar
  35. 27.
    H. O. J. Collier, W. A. Klee, A. Hertz, and R. A. North, in: Mechanisms of Pain and Analgesic Compounds (R. F. Beers, Jr., and E. G. Bassett, eds.), Raven Press, New York (1979).Google Scholar
  36. 28.
    G. Koski and W. A. Klee, Proc. Natl. Acad. Sci. USA 78, 4185 (1981).PubMedCrossRefGoogle Scholar
  37. 29.
    H. O. J. Collier, Nature 238, 625 (1980).CrossRefGoogle Scholar
  38. 30.
    P. Y. Law, D. S. Horn, and H. H. Loh, Molec. Pharmacol. 23, 26 (1983).Google Scholar
  39. 31.
    B. E. B. Sandberg and L. L. Iverson, J. Med. Chem. 25, 1009 (1982).PubMedCrossRefGoogle Scholar
  40. 32.
    T. L. Yaksh, D. H. Farb, S. E. Leeman, and T. M. Jessell, Science 206, 481 (1979).PubMedCrossRefGoogle Scholar
  41. 33.
    M. F. Piercey, L. A. Schoeder, K. Folkers, J.-C. Xu, and J. Horig, Science, 214, 1361 (1981).PubMedCrossRefGoogle Scholar
  42. 34.
    Martindale: The Extra Pharmacopoeia, 28th ed., p. 1001, 1031, The Pharmaceutical Press, London (1982).Google Scholar
  43. 35.
    G. deStevens (ed.), Analgesics, Academic Press, New York (1965).Google Scholar
  44. 36.
    D. Lednicer (ed.), Central Analgesics, Wiley, New York (1982).Google Scholar
  45. 37.
    Prog. Med. Chem. 2, 43 (1962); 4, 171 (1965); 7, 229 (1970); 14, 249 (1977); 17, 1 (1980).Google Scholar
  46. 38.
    Prog. Drug. Res. 5, 155 (1963); 8, 261 (1965); 20, 45 (1976); 22, 149 (1978).Google Scholar
  47. 39.
    Adv. Drug. Res. 6, 79 (1971).Google Scholar
  48. 40.
    Annual Reports in Medicinal Chemistry, Vols. 1 (1965) to 18 (1983), Academic Press, New York.Google Scholar
  49. 41.
    Annual Review of Pharmacology, Annual Reviews, Inc., Palo Alto, 11, 241 (1971); 15, 29 (1975); 20; 81 (1980).Google Scholar
  50. 42.
    M. R. Johnson and G. M. Milne, in: Burger’s Medicinal Chemistry, 4th ed. Part III (M. E. Wolff, ed.), p. 699, Wiley, New York (1981).Google Scholar
  51. 43.
    P. A. J. Janssen and C. A. M. Van der Eycken, in: Drugs Affecting the Central Nervous System (A. Burger, ed.), p. 25, Dekker, New York (1968).Google Scholar
  52. 44.
    D. Lednicer and L. A. Mitscher, The Organic Chemistry of Drug Synthesis, Vol. 1, p. 286 (1977), Vol. 2, p. 314 (1980), Wiley, New York.Google Scholar
  53. 45.
    M. C. Brande, L. S. Harris, E. L. May, J. P. Smith, and J. E. Villarreal (eds.) Narcotic Antagonists, Raven Press, New York (1973).Google Scholar
  54. 46.
    M. W. Adler, L. Manara, and R. Samanin (eds.), Factors Affecting the Action of Narcotics, Raven Press, New York (1978).Google Scholar
  55. 47.
    Life Sci. 31, 1185, 1645, 3165 (1982); 33, 1 (Suppl. 1) (1983).Google Scholar
  56. 48.
    Nature, 278, 394 (1979); 279, 13 (1979); 306, 739 (1983).Google Scholar
  57. 49.
    Pharm. J. 223, 206 (1979); 231, 269 (1983).Google Scholar
  58. 50.
    K. Blum, Handbook of Abusable Drugs, Gardner Press, Inc., New York (1984).Google Scholar
  59. 51.
    P. D. Wall and R. Melzack (eds.), Textbook of Pain, Churchill Livingstone, Edinburgh (1984).Google Scholar
  60. 52.
    R. Melzack, Pain Measurement and Assessment, Raven Press, New York, (1983).Google Scholar
  61. 53.
    H. N. Bhargava, in: Handbook of Stereoisomers: Drugs in Psychopharmacology (D. F. Smith, ed.), CRC Press, Boca Raton, Florida (1984).Google Scholar

Copyright information

© Springer Science+Business Media New York 1986

Authors and Affiliations

  • Alan F. Casy
    • 1
  • Robert T. Parfitt
    • 1
    • 2
  1. 1.University of BathBathUK
  2. 2.Canberra College of Advanced EducationBelconnenAustralia

Personalised recommendations